June 19, 2015 – Mobile Payments: The TMT Perspective
June 9, 2015 – GOOG: A Particular Set of Skills
May 28, 2015 – TMT Model Portfolio Update: The Skeptics Guide
May 15, 2015 – SaaS Applications: [Subscription] Software is Eating the World!
May 5, 2015 – TMT: 1Q 2015 Earnings Rundown
April 28, 2015 – AAPL: iPhone 6 Upgrades Setting Up a Difficult Compare
April 20, 2015 – TMT: 1Q 2015 Earnings Preview
April 15, 2015 – Mobile Commerce: AAPL and GOOG Have Home Field Advantage
March 30, 2015 – QCOM: The Sun Comes After the Rain
March 12, 2015 – Digital Advertising: The 7 Habits of Highly Effective Ad Platforms
March 10, 2015 – AAPL: High Priced, Cause it Feels So Nice
February 23, 2015 – TMT Model Portfolio Update: Escaping the Death Watch
February 10, 2015 – Net Neutrality: Reining in the Dumb Pipe Oligopoly
February 5, 2015 – Quick Thoughts: TWTR – BOOM! There’s MAUs in Them Thar Tweets
February 3, 2015 – Advertising: The “Golden Age” of TV Enters its Golden Years
January 29, 2015 – Quick Thoughts: AMZN and GOOG – Looking for Some Investor Love
January 28, 2015 – Quick Thought: FB and QCOM – Beat, Guide and Drop
January 28, 2015 – Quick Thoughts: AAPL – Awesome! Epic! When Should We Sell?
January 26, 2015 – Quick Thoughts: MSFT – Moving Quickly to the Cloud
January 21, 2015 – Quick Thoughts: MSFT – Mobile First, Cloud First, CHECK!
January 20, 2015 – Quick Thoughts: NFLX – What a Difference a Quarter Makes
January 14, 2015 – Ten Investible Things That We Think Will Happen in 2015
December 22, 2014 – Net Neutrality: Treating the Symptoms Rather than the Disease
December 1, 2014 – Twitter: Black and Blue, but Read All Over
November 19, 2014 – Quick Thoughts: Qualcomm Analyst Day – Hang On for a Bumpy Ride
November 13, 2014 – Quick Thoughts: Twitter Stops the Bleeding
November 10, 2014 – SaaS Revisited: Still Growing After All These Months
November 5, 2014 – Quick Thoughts: QCOM – Little Trouble in Big China
October 30, 2014 – TMT: Portfolio Update – Dreams, Comebacks, Skeptics and the Death Watch Redux
October 27, 2014 – Quick Thoughts: TWTR 3Q14 – It’s Always Something
October 23, 2014 – Quick Thoughts: MSFT – Not Your Father’s Microsoft
October 23, 2014 – Quick Thoughts: AMZN – OOPS! He Did it Again!
October 21, 2014 – Sensors: What’s in YOUR Smartphone?
October 20, 2014 – Quick Thoughts: AAPL – Surprise! AAPL beats! (actually, not a surprise)
October 16, 2014 – Quick Thoughts: GOOG – Moonshots are Expensive
October 15, 2014 – Quick Thoughts: NFLX – One Strike is Not an Out
October 6, 2014 – Quick Thoughts: HPQ – Another 180 Degree Turn, But Still No Strategic Direction
October 3, 2014 – Consumer Data: It’s Not Just What You Have, It’s Also Knowing What to Do With It.
September 30, 2014 – Quick Thoughts: eBay – OK Carl, Just Don’t Tell Us “I Told You So”
September 22, 2014 – Quick Thoughts: Apple Watch – All About the Benjamins
September 17, 2014 – Quick Thoughts: Apple’s growth is all about the iPhone
September 15, 2014 – Apple Pay: Friend (and Potential Foe) to the Payments Industry Status Quo
September 10, 2014 – Quick Thoughts: T-Mobile’s Uncarrior 7.0 Takes Aim at VZ/T’s Profits
September 9, 2014 – Quick Thoughts: Apple – Go Big or Go Home
August 19, 2014 – Infrastructure as a Service: The Race Won’t Go All the Way to the Bottom
July 24, 2014 – TMT: Portfolio Update – Sooner, or Later?
July 10, 2014 – Apple and Google: On Your Wrist and In Your Car
June 22, 2014 – US Telecom: Merger Mania! Telecom Bankers Rejoice!
June 9, 2014 – TMT: The Advertising Revolution Will NOT Be Televised
May 21, 2014 – TMT: “Culture Eats Strategy for Breakfast!”
May 8, 2014 – eBAY: Betting Big on the Future of Retail
April 15, 2014 – TMT: Don’t Rain on My IPO
March 26, 2014 – Facebook: Dream Until Your Dreams Come True
March 2, 2014 – SaaS: After the Levee Breaks – Competition in Software
February 6, 2014 – Google: King of the Kloud Krewe
January 22, 2014 – Apple: Is Apple the New Microsoft?
January 6, 2014 – TMT: 10 Predictions for 2014
December 11, 2013 – TMT: The Good, the Bad and the MEH
November 25, 2013 – TMT: How the Mighty Can Fall
November 3, 2013 – Twitter: Out of the Nest, Into the Sky
October 23, 2013 – Twitter: There’s Gold in Them Thar Tweets
October 8, 2013 – Twitter: How Tweet it is!
October 1, 2013 – Smartphones Today: Looking High and Low
September 18, 2013 – Mobile Payments: Incumbents versus Innovators (AUDIO)
September 9, 2013 – Mobile Payments: From Cards, to Smartphones and the Cloud
September 3, 2013 – TMT Portfolio Updates: Walking the Topline
August 1, 2013 – Mobile Devices: The PC-ification of the Smartphone
July 17, 2013: The War on TV Part IV: The Biggest Pipe Will NOT Win
July 2, 2013: The War on TV Part III – Reductio “Ad” Absurdum
June 19, 2013: The War on TV Part II – Streaming is Coming
June 12, 2013 – The War on TV: The Attack of the Boxes
May 21, 2013 – Data Center Spending: We Don’t Get Fooled Again!
May 1, 2013 – Qualcomm: Whadda We Gotta Do to Get Some Respect Around Here!
April 19, 2013 – TMT Portfolio Updates: The IPOs are Coming! The IPOs are Coming!
April 2, 2013 – US Wireless Carriers: The Barbarians are at the Gate
March 13, 2013 – Mobile Semiconductors: In Search of the One Chip Solution
March 4, 2013 – TMT: In the Year 2020 – 8 Things We Think
February 14, 2013 – Microsoft: No More Mister Softy!
January 30, 2013 – Amazon: In Jeff Bezos We Trust
January 16, 2013 – Facebook: Stuck in the Friend Zone
January 8, 2013 – Small Cap TMT: Time to Stop Feeding the Bear
December 26, 2012 – Large Cap TMT Valuation: It’s Never ALL in the Price
December 4, 2012 – Google: The Biggest Hammer in a World Full of Nails
November 19, 2012 – Apple: Can a Leopard Change its Spots?
October 25, 2012 – Storage: All Roads Lead to the Cloud
October 3, 2012 – Wireless Carriers: Will the iPhone5 or New Spectrum Revive Carrier Competition?
September 11, 2012 – TMT in 2Q12: Investing for a Three Platform World
August 21, 2012 – Social Networking: The Millennial Application Moves Out of its Parents’ Basement
July 30, 2012 – Cloud Data Centers: Bigger, Faster, Cheaper!
July 12, 2012 – Online Video: Objects in the Mirror May be Closer than they Appear
July 2, 2012 – Portable Devices: Parts is Parts
June 12, 2012 – TMT Paradigm Shift! Which Side are You On?
May 29, 2012 – Video Advertising: The Incredible Disappearing Audience
May 15, 2012 – The Internet Revolution: It’s Not Social OR Mobile, It’s Apps
April 26, 2012 – Cheap Tech Redux: Sifting Through the Bargain Bin Again
April 2, 2012 – Telecom Carriers: Why Aren’t These Cyclicals Cycling?
March 15, 2012 – Television Networks: Betwixt and Between a World of Change
March 5, 2012 – 4Q11 Earnings Update: Plenty of Runway for Cloud Leaders
February 13, 2012 – The Future of Video Advertising: Three-screens, #hashtags, and Streams
January 31, 2012 – Multichannel TV: What, Me Worry?
January 19, 2012 – Virtualization and the Cloud
January 9, 2012 – Enterprise IT: Send in the Clouds
December 16, 2011 – The Four Horsemen of the Internet
December 1, 2011 – TMT in 3Q11 – Temporary Flight to Value But New Paradigm Growth Apparent
November 17, 2011 – The Open Source Software Threat
October 31, 2011 – Mobile Processors: Here, There, and Everywhere
October 13, 2011 – TMT M&A: Fat Wallets and Attractive Targets
September 19, 2011 – Patent Wars!
September 7, 2011 – TMT in 2Q11: Debt Crisis Aftermath Leaves Value Opportunities in Growth Themes
August 24, 2011 – Mobile Platforms: Integrating Everything
July 13, 2011 – Online Payments: Cut Up Your Credit Cards!
June 22, 2011 – Mobile Devices: Flying in the Clouds
June 7, 2011 – Cheap Tech: A Guide for Cautious Bottom Fishing
May 20, 2011 – Large Cap TMT: The Curse of Great Expectations – Launching a Model Portfolio
May 11, 2011 – Small Cap TMT: Time for a Three Month Check Up
April 21, 2011 – Internet Everything: The Coming War for the Consumer
April 13, 2011 – Energy IT: Green is Good
March 23, 2011 – Enterprise IT and the Cloud
March 9, 2011 – 4G: Faster, Cheaper, Better
February 24, 2011 – Mobile Advertising: Check In, Then, Check Out
February 8, 2011 – Small Cap TMT: The Idiosyncratic Method
January 24, 2011 – Storage:Disrupt This!
January 6, 2011 – Online TV: A Cycle Ride to The Tipping Point
December 22, 2010 – Net Neutrality: The FCC Takes Over the Top Under its Wing
December 7, 2010 – Enterprise IT Spending: Worry About the Government
November 22, 2010 – 4G: The Cure for the Common Cord
November 1, 2010 – Streaming On-line, On-Demand Video: Over-the-Top, On the Way
October 18, 2010 – It’s Not Just Advertising … It’s New and Improved Advertising!
September 30, 2010 – Large Cap Tech: The Revolution Will Be Streamed
September 11, 2010 – The Internet Core: We Can Rebuild it – We Have the Technology
August 24, 2010 – Portable Devices: Smartphones, and Tablets and Netbooks, Oh My!
August 12, 2010 – Internet TV: Extreme Make Over – Industry Edition
July 28, 2010 – PCs: Raging at the Dying of the Light
July 15, 2010 – Clouds: Who Will Get the Silver Lining?
June 30, 2010 – Apple vs. Google: Handicapping the Coming Battle for TMT Supremacy
June 15, 2010 – The Coming LED Lighting Revolution
June 2, 2010 – Enterprise Software Giants on the Prowl: Sorting Out M&A Targets
May 18, 2010 – The FCC “Gets It” – Competition, Not Market Power, Drives Innovation and Investment
May 3, 2010 – The Big Future of E-Learning: Beyond a Countercyclical Bump and a Student Loan Scare
April 22, 2010 – Quick Thoughts: Lower Subsidies Will Delay Handset Recovery
April 20, 2010 – A Thousand Paper Cuts: The Future of Cable TV
April 5, 2010 – The National Broadband Plan: Windfall for Wireless, but Catastrophe for Carriers
March 16, 2010 – TMT: The Only Constant is Change [INITIATING COVERAGE OF TMT]
June 22, 2015 – SSR Industrials & Materials Small-Mid Cap Rankings, June 2015
June 16, 2015 – June Chemicals Monthly: Treading Water
June 5, 2015 – DuPont Question 2: Chemours is a No Win Scenario
June 5, 2015 – Skepticism + Positive Revisions = Outperformance
May 29, 2015 – Deere – Not in the Headlights
May 27, 2015 – DuPont – Question 1: Is the Return on R&D Investment Positive?
May 22, 2015 – SSR Industrials & Materials Small-Mid Cap Rankings, May 2015
May 18, 2015 – May Chemicals Monthly: Activisms
May 13, 2015 – The DuPont Vote – Short Term Noise – Change is Coming Either Way
May 12, 2015 – Corporate Complexity – Less Is More
May 6, 2015 – EMN – Time to Focus on the Shareholders
April 27, 2015 – DD and DOW – Backing The Activists
April 23, 2015 – SSR Industrials & Materials Small-Mid Cap Rankings, April 2015
April 22, 2015 – TRN – Options Abound
April 20, 2015 – Air Products is Running Out of Gas – Praxair is Refueling!
April 20, 2015 – April Chemicals Monthly: Short Term Spikes
April 17, 2015 – Share Buybacks – Borrow While You Can?
April 6, 2015 – Increasing Dividend Payouts – Are Current Policies Appropriate?
March 31, 2015 – Small Cap Optimism – Same Results as the Big Guys
March 23, 2015 – Searching for Small-Mid Cap Ideas in Industrials & Materials
March 17, 2015 – Alcoa – A Transformation Story at a Bargain Price
March 16, 2015 – Chemicals Monthly: Outlook Still Cloudy
March 11, 2015 – Optimistic Managements = Poor Capital Allocation = Stock Underperformance
March 9, 2015 – Prices Falling, Dollar Rising – Stocks Defying Gravity
March 3, 2015 – Domtar (UFS) Wants to Talk about Incontinence, Market Doesn’t Care
February 19, 2015 – SWK – Significant Step Up in Cash Flow and Still Cheap
February 18, 2015 – Chemicals Monthly – Volatility:Crude and Activists
February 9, 2015 – Industrial Gases – Pricing Coming and Good for All
January 27, 2015 – US Ethylene – Who Will Blink First
January 20, 2015 – BLL & CCK: It’s the Geography, Stupid
January 20, 2015 – Another Buying Opportunity in Alcoa
January 20, 2015 – Chemicals Monthly: Free Falling
January 13, 2015 – Own Goal Investing – EMN Presents Another Opportunity
January 12, 2015 – Favorites for 2015 & Industrials & Materials Methodology Review
January 5, 2015 – The Ethylene Conundrum: EMN the Value Play
December 17, 2014 – Chemicals Monthly: Race to the Bottom
December 15, 2014 – Skepticism Index: Don’t Be Skeptical
December 9, 2014 – Weaker Global GDP Suggests Some Heroic Expectations/Assumptions
December 8, 2014 – LYB and DOW – A Holiday Present From Europe With Interesting Implications
December 8, 2014 – Paper & Packaging – Seasonality Strong, Expect Outperformance in December
December 4, 2014 – LyondellBasell and Westlake – Not Yet!
December 4, 2014 – Large Cap Value – Where to Look if Santa Comes to Town
November 24, 2014 – Praxair – An Unusual GARPY Opportunity
November 21, 2014 – A Capital Goods View – Europe & China
November 18, 2014 – Chemicals Monthly – Spoiled For Choice
November 11, 2014 – Eastman: A Good Story, But At Risk Of A Complexity “Own Goal”
November 10, 2014 – The China OCC Question
November 6, 2014 – Capital Allocation – Why The Activists Are Where They Are
October 31, 2014 – The Power of Positive Thinking – APD and the DD read-through
October 20, 2014 – Looking Among the Small Cap Rubble to Find Opportunities
October 16, 2014 – Commodity Chemicals – Overdone? Maybe Not
October 16, 2014 – Chemicals Monthly – A Whole New World
October 2, 2014 – DuPont Can Be A Bad Stock: If Trian is Right, But Gives Up
September 23, 2014 – Why 2015 Could Be A Short Sharp Storm For US Ethylene
September 17, 2014 – Rising Dollar and Falling Crude – Bad For Commodity Chems
September 15, 2014 – Chemicals Monthly – Revisions Down but Stocks Up
September, 10 2014 – BLL & CCK – Can Makers Not Cheap
September 9, 2014 – Marcellus Opportunity: Why We Should See More Chemical Investment
August 18, 2014 – Deere: Earnings Risk Still Significant, But Likely Priced In
August 15, 2014 – Chemicals Monthly: Commodity Chemicals Roll On
August 14, 2014 – US Ethylene: It’s a Record Breaker – But No One Really Wins Quickly Anymore
August 12, 2014 – To Russia, But Not With Love – Right Now
August 1, 2014 – Monthly Review August 2014: Earnings Season Unkind to Industrials & Basics
July 31, 2014 – CAT: Now Mining Matters – And Trends Are Better
July 28, 2014 – Industrial Gases: APD Must Focus on Costs, But PX the Better Investment
July 23, 2014 – DuPont: Ag-rivating, But Unlikely to Change Without Action
July 15, 2014 – Chemicals Monthly: Albemarle Active, Gases Gain
July 1, 2014 – Monthly Review July 2014: Commodity Chemicals Stretching the Limits
June 22, 2014 – Aluminum: Perhaps Too Cautious Too Soon!
June 20, 2014 – Chemicals Monthly: All Eyes on Iraq
June 16, 2014 – European Basic Chemicals: There Is Life In The Old Dog Yet!
June 2, 2014 – DuPont: A Cost Initiative Could Be Substantial
June 1, 2014 – Monthly Review June 2014: Valuation Dispersion Elevated as Markets Stretch Higher
May 16, 2014 – Chemicals Monthly: Weathering the Storm Well
May 15, 2014 – Chemicals Revisions: Not Positive Enough and Not Supportive of Values for Many
May 13, 2014 – DuPont: The Case for $85 – But Why We May Need to be Patient
May 12, 2014 – Large Cap Capital Goods: Turning a Revisions Corner – Time for the Laggards to Win
April 30, 2014 – Monthly Review May 2014: What Weather? Earnings Strong Even With GDP Sluggish
April 29, 2014 – Dow Vs Lyondell: Bet on the Company With More Levers to Pull – DOW
April 28, 2014 – China Slowdown? The Real Risk is Exports
April 28, 2014 – US Natural Gas: Not Out of the Woods Yet!
April 25, 2014 – Air Products and Praxair: A Tale of Two Strategies
April 21, 2014 – Alcoa: Self Help Can Take You Only So Far – Now We Need Pricing
April 15, 2014 – Chemicals Monthly: A Volatile Market But Stable Energy
April 2, 2014 – SWK: Upside to Earnings and to Sentiment
March 31, 2014 – Monthly Review April 2014: March Madness No Cure as Industrials Lag in Q1
March 31, 2014 – Petrochemical-Fest: A Summary of the Texas Gathering
March 24, 2014 – Seeding a Better Investment
March 23, 2014 – Why the Basic Chemical Investments in the US Will Likely Disappoint
March 19, 2014 – Peak Valuation in Some Commodity Chemicals: Something to Watch
March 16, 2014 – Chemicals Monthly: All Getting Too Pricey
March 13, 2014 – After the Storm Clouds Clear: What to Buy on A Dip
March 6, 2014 – 14 for 14 Portfolio Update: February and YTD Performance
March 5, 2014 – APD: Time to Move to the Sidelines – PX More Interesting
February 24, 2014 – Dow: A More Optimal Path, But a Hard Destination to Reach
February 18, 2014 – Chemicals Monthly: Performance for the Commodity Companies Defies Costs
February 17, 2014 – Dow – Loeb versus Liveris – Watch From A Distance
February 3, 2014 – Should We Care About the Weather?
January 20, 2014 – Optimists Won in 2013, but Are Now More Optimistic and Much More Expensive
January 15, 2014 – Chemicals Monthly: A Better Fundamental Year – Or Not Enough?
January 9, 2014 – Chemical Companies in 2014
January 6, 2014 – 14 for 14: 7 Attractive and 7 Overvalued Mid Cap Companies
January 5, 2014 – 14 Attractive, Bad or Overhyped Ideas for 2014
January 1, 2014 – Monthly Review January 2014: Charging Into the New Year
December 30, 2013 – DD: Still An Interesting Investment
December 16, 2013 – US Ethylene: The Case For A Better 2014
December 16, 2013 – Chemicals Monthly: Looking Pricey as We Enter a New Year
December 10, 2013 – Exporting Shale: A More Logical Perspective
December 2, 2013 – Monthly Review December 2013: New Year Focus With Revisions Negative
November 18, 2013 – The Recommendation Signal: Another Reason to Look at DuPont
November 15, 2013 – Chemicals Monthly: Energy Volatility Distracts
November 7, 2013 – Lyondell: Growth or Income, Both Have Risk
November 6, 2013 – Valuation Spreads Extreme
October 31, 2013 – Monthly Review November 2013: Industrials Trail the Bull
October 29, 2013 – PPG: What Do You Have To Believe
October 28, 2013 – MOS/CF: Clever Bit of Financial Engineering for Both Companies
October 21, 2013 – Common Sense Restructuring: Some Money to Be Made
October 16, 2013 – Chemicals Monthly: More Concerns Than Opportunities
October 6, 2013 – The Case for Stanley: Why Reversion to the Mean Often Works
October 3, 2013 – Capital Goods: Unloved and Presenting Opportunities
October 1, 2013 – Monthly Review October 2013: Industrials Riding the Wave of Easy Money
September 26, 2013 – Return on Capital Jumps: Some Stretched Expectations
September 23, 2013 – The State of the US Chemicals Industry
September 16, 2013 – Chemicals Monthly: A Richer Sector With Limited Upside
September 16, 2013 – Optimism and Forecasting in the Chemical Industry
September 9, 2013 – Outliers: Where Valuation is Inconsistent with Return on Capital and Estimates
August 19, 2013 – Paint, A Band Wagon and Some Very Poor Analysis: Implications for PPG and RPM
August 16, 2013 – Chemicals Monthly: Chemicals Starting to Look Expensive (Except Ag)
August 5, 2013 – Understanding Transformational Change – The Eastman Example
August 1, 2013 – Monthly Review August 2013: Earnings Reveal Nothing New
July 25, 2013 – DuPont: Getting Appropriate Value for the Growth Engine
July 17, 2013 – Chemicals Monthly: Expecting Negative Revisions for 2H 2013
July 11, 2013 – Q2 2013: Not the Brightest of Outlooks Expected
July 1, 2013 – July Monthly: Midway Through the Year, Metals Still Searching For a Floor
June 19, 2013 – Time to Let the CAT Out of the Bag
June 19, 2013 – Complexity, Volatility and a Market Where Neither Extremes Work Well
June 17, 2013 – Chemicals Monthly: A Mixed Month Midway Through 2013
June 3, 2013 – Monthly Review June 2013: Industrials Reflect the Housing Comeback
May 30, 2013 – Capital Goods: Time to Play the Valuation Card
May 14, 2013 – Chemicals Monthly: Outperformance Despite Negative Revisions
May 13, 2013 – DuPont: Betting the Farm – But Perhaps a Need to Crop the Portfolio?
May 9, 2013 – Getting Left Behind in the Market – Unless You Have A Story
May 2, 2013 – Monthly Review May 2013: Bulls Rave On, Industrials Sit on the Sidelines
April 25, 2013 – Price Weakness In A Slow Market – Can It Be Different This Time
April 16, 2013 – Chemicals Monthly: Stagnant Demand Undermining Pricing and Confidence
April 10, 2013 – US Energy Advantage: Unintended Consequence; Global Overbuilding of Petrochemicals
April 2, 2013 – Q1 2013: A Revisions Driven Quarter – Not Good For Our January Picks
April 2, 2013 – Aluminum: Always Darkest Before the Dawn
April 1, 2013 – Monthly Review April 2013: Capital Goods Out Of Favor
March 18, 2013 – Investing Around R&D: Looking For the Companies Losing the Least
March 15, 2013 – Chemicals Monthly: A Few Cheap Stocks with Housing/Construction Exposure
March 5, 2013 – R&D in Industrials and Basics: Just Not Effective
March 4, 2013 – Monthly Review March 2013: More of the Same for the Industrials
February 15, 2013, – Chemicals Monthly: Cautious Guidance Appropriate, But A Drag On Performance
February 12, 2013 – US Basic Chemicals Economics: It Can’t Get Much Better Than This
February 4, 2013 – Monthly Review February 2013: Economic Uncertainty Rules The Day
February 1, 2013 – Optimists Are Everywhere and Most Underperform: A Quick Look at the S&P 500
January 25, 2013 – DuPont: The Uncomplicated Story and The What If?
January 16, 2013 – Chemicals Monthly: Expanding Feedstock Advantage = Higher Values
January 10, 2013 – A Lesson in Expectations: Is There a Bubble In My Paint?
January 3, 2013 – 13 Attractive, Bad or Overhyped Ideas for 2013 Assuming No Macro Change
January 2, 2013 – Monthly Review January 2013: Basic Materials Set to Open the Year At Extremes
December 18, 2012 – Chemicals Monthly: The Rise (or Fall) of Propane
December 10, 2012 – Over-confidence Destroys Value
December 3, 2012 – Monthly Review December 2012: Post Election, Industrials See More of the Same
November 29, 2012 – Guidance Matters: Even for Chemicals
November 27, 2012 – Getting the Guidance Right: Some Sectors Are More Self Aware Than Others
November 19, 2012 – Chemicals Monthly: Down Come the Estimates – Again
November 5, 2012 – Monthly Review November 2012: End of Year Questionable as Earnings Disappoint
October 25, 2012 – Unyielding: The Supposed Thirst For Dividend Growth
October 17, 2012 – October Chemicals Monthly: Coated in Glory, But Looking Like a Peak
October 11, 2012 – Earnings Preview: Expectations Vary Widely, Valuations Equally
October 9, 2012 – Commodity Chemicals: Building In the US, an Adventure or an Investment
October 1, 2012 – Monthly Review October 2012: A Month of Mixed Messages
September 24, 2012 – Chemicals Monthly: Cost Advantage Either Priced In Or Not Evident
September 7, 2012 – Grossly Different: Gross Margin Trends Speak (Offset) Volumes
September 5, 2012 – Gross Expectations: Why the Paper Bet is a Bold One
September 4, 2012 – Monthly Review September 2012: Strong Showing for the Industrials
August 13, 2012 – Deal Flow Update: Big Cash Premiums Limit Odds of Success
August 7, 2012 – Monthly Review August 2012: Positives Driven By Cost Control
July 13, 2012 – Chemicals: Significant, Rather Than Incremental, Risks to 2H
July 10, 2012 – Housing: A Bright Spot, But Not Enough on Its Own
July 2, 2012 – Monthly Review July 2012: Still No Overall Reason To Get Excited
June 25, 2012 – Europe: A Big Deal and Unevenly Discounted
June 15, 2012 – Transports: Travelling Well
June 7, 2012 – Sector & Sovereign Industrials & Basic Materials: Monthly Review June 2012
June 5, 2012 – Inventory/Sales Follow Up
June 1, 2012 – Significant Downside Risk From An Inventory Correction – The Stars Are Aligned
May 29, 2012 – Industrials and Basics: We Should Be Deal Shy
May 14, 2012 – Chemicals Skepticism: A Wide Divergence, Commodities vs. Coatings
May 2, 2012 – The SSR Industrials & Basic Materials Skepticism Index
April 30, 2012 – Q1 So Far: Some Tears, Some Laughter, No Real Conviction
April 16, 2012 – Metals and Mining: Discounting Much More Than Appears To Be Going On
April 11, 2012 – North American Commodity Chemicals: Shale Gale Maybe, Windfall More Definitely
September 13, 2016
Is This the Golden Age of Electric Utilities? A Primer on Historical and Forecast Rate Base Growth
June 23, 2015 – CVS/TGT: What Does the Store-In-Store Strategy Mean for RAD?
June 16, 2015 – SNY/REGN: When to Expect Outcomes Data for Praluent
June 16, 2015 – A Strategic Look at CVS/TGT; Why We’re Still Bullish on RAD
June 7, 2015 – ACA at the Supreme Court: Subsidies Are Here to Stay, Even if SCOTUS Finds for King
June 2, 2015 – US Drug Pricing Stalls. Uh-Oh …
May 4, 2015 – A WBA/RAD or CVS/RAD NEWCO as a Counterweight to Narrowing Retail Pharmacy Networks
May 4, 2015 – SSR Health New Product Approval Portfolios & Supporting Data Update
April 21, 2015 – ABC/CAH/MCK: US Generic Inflation Continues in 1Q15
April 15, 2015 – ABBV/PCYC: Imbruvica and ABT-199 are Synergistic
April 13, 2015 – SNY: The (multi-faceted) Bull Case
April 6, 2015 – CVS, MCK, RAD, WBA: How WBA or CVS can fight narrowing retail networks – buy RAD
March 30, 2015 – AMGN, SNY, REGN, LLY, MRK, & ESPR: PCSK9 v. CETP v. ETC-1002
March 17, 2015 – AMGN, REGN, SNY: Bull Case for PCSK9’s; COGS a Major Advantage for SNY/REGN
March 12, 2015 – ABBV/PCYC: Imbruvica’s US Pricing Has Room to Grow
February 25, 2015 – WBA, CVS, RAD: There Are Simply Too Many Pharmacies & Now it Starts to Matter
February 17, 2015 – SSR Health New Product Approval Portfolios & Supporting Data Update
February 9, 2015 – Motive & Opportunity: The Convoluted Tale of Generic Price Inflation
February 5, 2015 – Why ABBV is Still a Value
January 23, 2015 – The Bull Case for SNY’s Diabetes Franchise – Update
January 20, 2015 – The Outlook for Brand Drug Pricing Part 1: The Traditional Large-Cap Pharmaco’s
January 9, 2015 – Flu Effects on 4Q14 Earnings
December 22, 2014 – ABBV HCV Regiment Approved; Further Upward Revisions to Consensus Likely
December 8, 2014 – SSR Health New Product Approval Portfolios & Supporting Data Update
December 5, 2014 – The Bull Case for SNY’s Diabetes Franchise
November 17, 2014 – Hold-Out States Will Expand Medicaid – Just Ask History
November 11, 2014 – SCOTUS Round II: Does King Really Matter?
October 20, 2014 – SSR Health New Product Approval Portfolios & Supporting Data Update
October 6, 2014 – Healthcare & the Midterm Elections: Everything You Need to Know
September 2, 2014 – ABBV (and ENTA): The Corvette(s) to GILD’s Ferrari
August 12, 2014 – SSR Health New Product Approval Portfolios & Supporting Data Update
July 28, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Final 2Q14 Estimates
July 10, 2014 – SSR Health New Product Approval Portfolios & Supporting Data Update
July 7, 2014 – The Bull Case for Specialty Drug Pricing
June 25, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Interim 2Q14 Estimates
June 24, 2014 – Net HIE Premiums Growing Faster Than Incomes; This is Likely to Accelerate
June 17, 2014 – Early Look at 2015 HIE Rates: Avg. Increase = 10%
June 3, 2014 – SSR Health New Product Approval Portfolios & Supporting Data Update
May 23, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Initial 2Q14 Estimates
May 9, 2014 – BIG Monkeys & a Looming Intervention: Pharma’s US Pricing Addiction
May 8, 2014 – Co-Pay Cards & the Stalling of Drug Rebate Growth Part II – The HIE ‘Test Case’
May 5, 2014 – MRK: R&D Productivity, as Compared to Peers
April 28, 2014 – SSR Health New Product Approval Portfolios & Supporting Data
April 23, 2014 – PFE/AZN: R&D Productivity in the Context of a Theoretical Merger
April 21, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Final 1Q14 Estimates
April 16, 2014 – Medicaid HMOs: Growth Prospects Undervalued
April 14, 2014 – ACA Enrollment Round-Up
April 7, 2014 – Index of Generic Drug Acquisition Costs Now Available to Pharmacies Nationwide
April 2, 2014 – The Bull Case for PCSK9 (AMGN, SNY, REGN, PFE): Why Estimates Are Too Low
March 25, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Interim 1Q14 Estimates
March 5, 2014 – The Trouble with Hospital Pricing
February 26, 2014 – SSR Index of Current-Quarter Healthcare Demand Growth: Initial 1Q14 Estimates
February 20, 2014 – ACA Enrollment and Adverse Selection Pressures – An Update
January 20, 2014 – Adverse Selection on the HIEs – It’s Not (Just) About the Federal Website
January 7, 2014 – MRK v. AMGN: A Comparison of R&D Productivity
December 17, 2013 – SSR Index of Current-Quarter Healthcare Demand Growth: Interim 4Q13 Estimates
November 26, 2013 – SSR Index of Current-Quarter Healthcare Demand Growth: Initial 4Q13 Estimates
October 24, 2013 – LLY: Whether High R&D/Sales is Defensible – an Empiric Dissent
October 17, 2013 – DVA / FMS: Generic Epogen Accretive to EPS
September 18, 2013 – SSR Index of Current-Quarter Healthcare Demand Growth, Interim 3Q13 Estimate
September 4, 2013 – Evidence of Rate Shock on the Individual HIEs: Weak at Best
August 30, 2013 – SSR Index of Current Quarter Healthcare Demand Growth, Initial 3Q13 Estimate
August 27, 2013 – Medicaid HMOs: More Growth, Less Risk
July 22, 2013 – Premium Inflation on the HIEs – Case Study of the California Individual Market
July 18, 2013 – SSR Index of Current Quarter Healthcare Growth, Final 2Q13 Estimate
July 8, 2013 – The Practical Relevance of the Employer Mandate Delay
June 26, 2013 – The SSR Healthcare Quarterly, Inaugural Edition
June 20, 2013 – SSR Index of Current Quarter Healthcare Growth, Interim 2Q13 Estimate
May 28, 2013 – PBM Bear Thesis Update: The AWP Alternatives Will Soon Be Here
May 20, 2013 – SSR Index of Current Quarter Growth, Initial 2Q13 Estimate
May 16, 2013 – Buckle Up! A Summary of Adverse Selection Pressures on Health Insurance Exchanges
May 7, 2013 – Cheap, Shy or Just Misbehaving? PFE Sells Viagra Direct to Consumers
April 29, 2013 – Why Smaller Employers Will Shift to Self-Funding; Who Wins and Loses
April 19, 2013 – SSR Index of Current-Quarter Healthcare Demand Growth, Final 1Q13 Estimate
April 9, 2013 – SSR Index of Drug and Biotech Pipeline Values
April 2, 2013 – Private Health Exchanges: Why They’re Coming; What They Mean
March 20, 2013 – WAG/ABC – Quick Strategic Read-thru; Better for WAG than ABC
March 19, 2013 – The Razorback Alternative: Is Arkansas’ Medicaid Game Plan a Blueprint for Others?
March 18, 2013 – SSR Index of Current-Quarter Healthcare Demand Growth, Interim 1Q13 Estimate
March 11, 2013 – Hedge Hospital Pricing Risks with Non-Rx Consumables
March 4, 2013 – The Medicaid Expansion & Why Hospital Pricing Peaks in 2013
February 26, 2013 – SSR Index of of Current Quarter Healthcare Demand Growth, Initial 1Q13 Estimate
February 11, 2013 -Investment Recommendations Across Healthcare, by Sub-Sector
January 16, 2013 – Flu Effects on US Health Demand
January 15, 2013 – The Incredibly Slow (But Very Nearly Certain) Death of AWP
December 17, 2012 – Why Medicaid Eligibility Will (Still) Level Off at 100 FPL
December 4, 2012 – A Simple Formula for Drug (and Biotech and Spec Pharma) Stock Selection – Updated
November 19, 2012 – SSR Index of Current-Quarter Healthcare Demand Growth, Initial 4Q12 Estimate
November 8, 2012 – An Index of the Value in Large Cap PharmaCos’ Mid- to Early-Stage Pipelines
October 22, 2012 – SSR Index of Current-Quarter Healthcare Demand Growth, Final 3Q12 Estimate
October 15, 2012 – US Healthcare Demand Part 4: Cyclical Effects
October 1, 2012 – US Healthcare Demand Part 3: Reform Effects – ACA Looks Like a Headwind
September 17, 2012 – US Healthcare Demand Part 2: Secular Headwinds
September 4, 2012 – US Healthcare Demand, Part 1: ‘Baseline’ Growth
August 16, 2012 – SSR Index of Current-Quarter Demand Growth: Initial 3Q12 Estimates
August 8, 2012 – Co-Pay Cards: A Bottle for the Drug Pricing Genie
July 27, 2012 – Medicaid Eligibility Capped at 100 FPL: The Logical Outcome of the SCOTUS ACA Ruling
July 18, 2012 – SSR Index of Current-Quarter Demand Growth; Lowering Estimate Back to 3.1% from 3.3%
June 29, 2012 – ACA Post-SCOTUS – What Matters Now
June 18, 2012 – SSR Index of Current-Quarter Demand Growth; Raising Estimate to 3.3% from 3.1%
June 14, 2012 – The Mechanics of Commercial HMOs’ Gross Profits: Why MLRs Should Remain Stable
May 31, 2012 – The Apparent Link Between Employment and Healthcare Demand
May 17, 2012 – Why HMOs are Cheap, Despite Rising Utilization
May 16, 2012 – SSR Index of Current-Quarter Healthcare Services Demand
February 26, 2012 – Large cap Pharma’s Dependence on US List Price Growth is Unsustainable
February 6, 2012 – The Pro-Cyclical US Healthcare Thesis – Impact of ROW Economic Risks
January 24, 2012 – Hospitals’ Stable to Improving Net Pricing Power
January 12, 2012 – US Healthcare Demand Slow for Cyclical (Temporary) Reasons
November 14, 2011 – PBM Pricing Post-AWP – An Estimate of Sustainable Earnings Power
October 24, 2011 – ACA at the Supreme Court
October 11, 2011 – Below Zero and Falling Fast: Productivity as an Enterprise-Wide Crisis
October 6, 2011 – President’s Budget Proposal Points to More Pressure on Innovators
October 3, 2011 – Detailed Comparison of the AWP Replacements – AMP v NADAC
September 26, 2011 – CMS Starts to (Kind of) Publish AMP
September 9, 2011 – A Simple Formula for Drug Stock Selection
August 18, 2011 – CMS Takes Concrete Steps Towards Replacing AWP
August 15, 2011 – Market Appears to Misprice Risks to Healthcare Earnings from BCA
August 3, 2011 – Healthcare and the Budget Control Act of 2011
July 25, 2011 – ESRX, MHS, and the PBM Bear Case
July 11, 2011 – Why Employer Are Likely to Drop Health Insurance: A Simplified View
June 10, 2011 – What Next for the MLR cycle?
May 24, 2011 – Can Shuffling the Deck Create Growth?
May 5, 2011 – The Thread Holding Generic Dispensing Margins
April 27, 2011 – The (Unfortunate) Irrelevance of ACOs
April 6, 2011 – CMS says AMP is Coming; Why Ortho Demand May Slow
March 22, 2011 – Medicaid Cost Pressures Intensify on the States
March 2, 2011 – Post-2014 Reform Related Volume Gains are Modest
February 11, 2011 – PFE Decides to Shrink; HHS ends AWP; and Drug Pricing Hits a Speedtrap
January 26, 2011 – Ranked Preferences Across Healthcare (Sub-sector by Sub-sector)
January 5, 2011 – Copay Cards and the Stalling of Drug Rebate Growth
December 1, 2010 – Demand Trend Improves Starting 4q; Why HDLC Drugs May be Bigger Than You Think
November 10, 2010 – Uncertainty and Motive in Pharmacy Dispensing Markups
October 29, 2010 – Why Generic Dispensing Margins (Eventually) Must Fall
October 4, 2010 – What a Republican House Means for Health Reform
September 22, 2010 – Skeptic’s Guide to Drug Stock Selection
September 7, 2010 – Why US Healthcare Demand Appears to be Falling
August 24, 2010 – Single-payor (read European) Governments and Your Healthcare Portfolio
July 29, 2010 – Consumers Add Risk; Insurers Add Power; Consequences for Providers and Suppliers
July 8, 2010 – Big Pharma’s Tenuous Grip on the Emerging Markets
June 15, 2010 – Why UNH and WLP Are Better Positioned for Reform Than AET or CI
May 26, 2010 – Why the Average Employer Will Drop Health Insurance in 2014
April 26, 2010 – Practical Boundaries of Health Insurance Regulation
March 29, 2010 – 3 Reform Realities That Aren’t Priced In
March 18, 2010 – Handicapping the Whip Count: Odds Still Against Passage
March 10, 2010 – PBM GMs: This Looks Like the End of the Cycle
March 4, 2010 – Last Chance: Betting the Ranch on a Weak Hand
February 26, 2010 – Post-Summit: Why Large Reforms Almost Certainly Can’t Pass
February 17, 2010 – Introducing our Healthcare Demand Model
February 3, 2010 – Health Insurers Antitrust Exemption
February 1, 2010 – Residual Reform Risks; Subsector Estimates Do Not Add Up
January 20, 2010 – The Political (As Opposed to Procedural) Death of Health Reform
January 12, 2010 – GMs Too High for Pharma, Too Low for HMOs; Why the House Won’t Roll Over
December 2, 2009 – Biggest Reform Worry No One is Watching, Labor, and Massachusetts
November 17, 2009 – Why Health Reform Legislation Won’t Pass; More About Insurers’ 2010 Margins
November 2, 2009 – HMO & PBM Margins Expand; Public Option Has the Blues
October 20, 2009 – Health Insurers 40% Undervalued
October 6, 2009 – The New Abnormal: Health Costs Derail Fiscal Recovery
September 21, 2009 – Why the Senate Finance Healthcare Bill Doesn’t Work
September 8, 2009 – Reform Unlikely to be Large; Risk to Insurers Falls
August 18, 2009 – Political Economics and Investment Relevance of American Health Reform